Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Herpes-treatment

 Starburst conjugates
In its broadest aspect, the present invention is directed to polymer conjugate materials comprising ...


 Intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A partially protected alcohol of the formula: ##STR10## wherein Y.sup.1 is selected ...


 Antiviral polynucleotide conjugates
OF THE INVENTION The present invention provides polynucleotide conjugates characterized by the ...


 Azlactone activated polyalkylene oxides conjugated to biologically active nucleophiles
OF THE PREFERRED EMBODIMENT The azlactone activated polyalkylene oxides of the present invention ...


 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
INCLUSIVE OF PREFERRED EMBODIMENTS We have discovered that linear block copolymers comprising ...


 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
The present invention provides for compounds having the formula: ##STR1## wherein R.sub.1 is ...


 Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
OF THE INVENTION The following examples are given to illustrate the invention, but should not be ...


 Polyoxypropylene/polyoxyethylene copolmers with improved biological activity
Although the prior art preparations of polyoxypropylene/polyoxyethylene block copolymers may have ...


 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A compound of the formula ##STR10## where (a) X.sup.1 is chlorine and X.sup.2 is ...


 Nucleic acid probes immobilized on polystyrene surfaces
We claim: 1. An article of manufacture for use in a solution phase nucleic acid sandwich ...


 Herpes treatment

Details
Inventors: Gerzon, Koert;
Assignee: BetaMED Pharmaceuticals, Inc. (Indianapolis, IN)
Primary Examiner: Goldberg; Jerome D.
Assistant Examiner:
Attorney, Agent or Firm: Barnes & Thornburg

L-lysine L-glutamate, when injected intradermally in the form of a sterile aqueous solution, or applied topically in the form of a cream, ointment, or lotion, is effective for treating and relieving the symptons of Herpes simplex I and II infections.

DETAILED DESCRIPTION I claim: 1.
A method for the control of herpes virus infections in man which comprises contacting the herpes lesions, topically or by injection, with a dose of L-lysine L-glutamate effective to control the said infections.
2.
A method as in claim 1 wherein the herpes lesions are treated topically with a cream containing an effective dosage of L-lysine L-glutamate.
3.
A method as in claim 1 wherein the herpes lesions are treated topically with an ointment containing an effective dosage of L-lysine L-glutamate.
4.
A method as in claim 1 wherein the herpes lesions are treated topically with a lotion containing an effective dosage of L-lysine L-glutamate.
5.
A method as in claim 1 wherein an effective dose of L-lysine L-glutamate in a sterile aqueous buffer is injected intradermally into a herpes-infected patient.
6.
A method as in claim 5 wherein said effective dose is between about 0.
5 and about 5 milligrams.
7.
A method as in claim 5 wherein said L-lysine L-glutamate is injected at a dosage of around 0.
5 to 2 mg once a week for a period of at least three weeks.




Description:
The present invention relates to viral infections of the herpes type, including in particular Herpes simplex I and Herpes simplex II.
More particularly, it relates to a method and means for the alleviation and control of such infections.
Man himself is the reservoir of herpes virus hominis.
It has been reported in one study that antibodies to herpes virus were found in 30-37% of college students, 62% of private patients, and more than 80% of ward service patients.
Although the virus is carried as a latent infection in a majority of individuals, in others an acute exacerbation of the activated virus takes place in a variety of forms and can be precipitated by a variety of factors, including traumatic factors such as sunlight, menstruation, and family upsets.
Cold sores or fever blisters are thought to be caused by Herpes simplex I, whereas the Herpes simplex II is thought to be the agent in genital herpes infections



Related patents
  Dense star polymers and dendrimers
OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is covalently bonded to at least one core branch, preferably at least two, ...
  Glycerin derivatives and inhibition of blood PAF
OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## wherein one of the residues R.sup.1, R.sup.2 and R.sup.3 is group U of ...
  Oligonucleotide derivatives and production thereof
Gist In view of the state of the art as described above, the present inventors have developed an immobilized oligonucleotide which is useful in purification of nucleic ...
  Process for synthesizing macrocyclic chelates
The invention is a process for synthesizing a 12 membered ring tetraaza macromolecule. The process involves condensing an amide of ethylene diamine having a general ...
  Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
I claim: 1. A method for producing a 1:1 protein:anitbody tioether-linked immunoconjugate as a predominant species, comprising the steps of: combining a protein selected ...
  Compositions for photodynamic therapy
I claim: 1. A pharmaceutical composition useful for photodynamic therapy which composition contains, as active ingredient, a conjugate of a porphyrin-type ...
  Amplifier molecules for enhancement of diagnosis and therapy
As used herein, an "amplifier" or "amplifier molecule" is a chemical compound having a multiplicity of terminal amine moieties, each serving as a locus to which one or ...
  Peptide-containing polyethylene glycol derivatives and application thereof
OF THE PREFERRED EMBODIMENTS The present invention will hereinafter be explained in more detail. The peptide-containing polyethylene glycol derivatives of the present ...
  Modified HIL-6
OF THE INVENTION Described below is the chemical modification with PEG of at least one amino group of polypeptides possessing IL-6 activities. This modification results ...
  Construction of geometrical objects from polynucleotides
By means of the present invention, DNA, RNA and similar polymers may be produced by synthesizing a double stranded segment, preferably with a loop at one end, cleaving ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved